Entresto 24 MG-26 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FGAJN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,626
Award facts
- Contract value 100% obligated
- $10,626.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,626.40 delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg–26 mg tablets (60-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial federal procurement portfolio primarily with the Defense Logistics Agency and its Medical Supply Chain. As a prime contractor on the Pharmaceutical Prime Vendor program, the company supplies an extensive range of pharmaceuticals and medical supplies—including brand-name and generic medications, vaccines, and specialized medical devices—to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. Entresto is a brand-name cardiac medication commonly prescribed for heart failure management, reflecting the company's role in delivering critical therapeutic products to military and federal medical networks.
Quick answers
Who was awarded contract SPE2DB25FGAJN?
SPE2DB25FGAJN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FGAJN worth?
The government has obligated $10,626 on SPE2DB25FGAJN.
Is contract SPE2DB25FGAJN an order under another contract?
Yes. SPE2DB25FGAJN is a delivery order under SPE2DB24D3015, an indefinite delivery contract.
Was contract SPE2DB25FGAJN competed?
The extent of competition for SPE2DB25FGAJN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award